Principal Financial Group Inc. cut its holdings in Exponent, Inc. (NASDAQ:EXPO - Free Report) by 23.5% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 131,421 shares of the business services provider's stock after selling 40,370 shares during the period. Principal Financial Group Inc. owned about 0.26% of Exponent worth $15,150,000 as of its most recent SEC filing.
Other institutional investors also recently bought and sold shares of the company. Inspire Advisors LLC raised its position in shares of Exponent by 1.3% during the 2nd quarter. Inspire Advisors LLC now owns 7,615 shares of the business services provider's stock worth $724,000 after acquiring an additional 98 shares in the last quarter. Caprock Group LLC lifted its position in shares of Exponent by 4.2% during the 2nd quarter. Caprock Group LLC now owns 3,296 shares of the business services provider's stock worth $314,000 after buying an additional 134 shares during the last quarter. Parkside Financial Bank & Trust boosted its holdings in shares of Exponent by 11.0% in the 2nd quarter. Parkside Financial Bank & Trust now owns 2,008 shares of the business services provider's stock valued at $191,000 after buying an additional 199 shares in the last quarter. Mitchell & Pahl Private Wealth LLC boosted its holdings in shares of Exponent by 3.7% in the 3rd quarter. Mitchell & Pahl Private Wealth LLC now owns 5,961 shares of the business services provider's stock valued at $687,000 after buying an additional 214 shares in the last quarter. Finally, Westside Investment Management Inc. purchased a new position in shares of Exponent in the 3rd quarter valued at $26,000. 92.37% of the stock is owned by hedge funds and other institutional investors.
Exponent Stock Down 1.4 %
EXPO traded down $1.23 on Friday, reaching $89.43. The company had a trading volume of 176,452 shares, compared to its average volume of 243,639. Exponent, Inc. has a 1 year low of $68.70 and a 1 year high of $115.75. The stock has a market capitalization of $4.54 billion, a PE ratio of 43.20 and a beta of 0.70. The stock has a 50-day moving average price of $97.47 and a 200-day moving average price of $102.03.
Exponent Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Friday, December 20th. Stockholders of record on Friday, December 6th were issued a $0.28 dividend. This represents a $1.12 annualized dividend and a dividend yield of 1.25%. The ex-dividend date was Friday, December 6th. Exponent's payout ratio is currently 54.11%.
Insider Buying and Selling
In other Exponent news, Director Carol Lindstrom sold 1,039 shares of the company's stock in a transaction that occurred on Monday, November 4th. The stock was sold at an average price of $96.32, for a total transaction of $100,076.48. Following the completion of the sale, the director now directly owns 5,871 shares of the company's stock, valued at $565,494.72. This represents a 15.04 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Paul R. Johnston sold 1,300 shares of Exponent stock in a transaction that occurred on Wednesday, November 20th. The shares were sold at an average price of $95.03, for a total value of $123,539.00. Following the completion of the transaction, the director now owns 59,406 shares in the company, valued at $5,645,352.18. This trade represents a 2.14 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 30,339 shares of company stock worth $3,103,065 in the last quarter. 2.10% of the stock is owned by insiders.
Exponent Profile
(
Free Report)
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.
Read More
Before you consider Exponent, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exponent wasn't on the list.
While Exponent currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.